Get started
Author

Chu Lin

Observed names: C. Lin, CHU LIN, Chu Tong Lin, Chu lin, Chuhuai Lin
ORCID: 0000-0002-2365-9831
Observed ORCID: 0000-0002-2365-9831
OpenAlex ID: A5086973761
Inflammasomes in Inflammation-Induced Cancer
2017 · Chu Lin, Jun Zhang · Frontiers in Immunology · 103
PDF
SGLT2 inhibitors and lower limb complications: an updated meta‐analysis
2021 · Chu Lin, Xingyun Zhu, et al. · Cardiovascular Diabetology · 77
PDF
Characterizing body composition modifying effects of a glucagon‐like peptide 1 receptor‐based agonist: A meta‐analysis
2024 · Ruoyang Jiao, Chu Lin, et al. · Diabetes Obesity and Metabolism · 59
The association between metabolic parameters and evening chronotype and social jetlag in non-shift workers: A meta-analysis
2022 · Rui Zhang, Xiaoling Cai, et al. · Frontiers in Endocrinology · 46
Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell
2018 · Chu Lin, Jun Zhang · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 42
The Effect of Physical Activity on Glycemic Variability in Patients With Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2021 · Xingyun Zhu, Lina Zhao, et al. · Frontiers in Endocrinology · 38
Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials
2024 · Zonglin Li, Chu Lin, et al. · Alzheimer s Research & Therapy · 36
PDF
The association between the use of sodium glucose cotransporter 2 inhibitor and the risk of diabetic retinopathy and other eye disorders: a systematic review and meta-analysis
2022 · Yunke Ma, Chu Lin, et al. · Expert Review of Clinical Pharmacology · 31
Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials
2023 · Zonglin Li, Chu Lin, et al. · Atherosclerosis · 29
PDF
The Urinary Glucose Excretion by Sodium–Glucose Cotransporter 2 Inhibitor in Patients With Different Levels of Renal Function: A Systematic Review and Meta-Analysis
2022 · Suiyuan Hu, Chu Lin, et al. · Frontiers in Endocrinology · 29
PDF
The Biological Disease‐Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta‐Analysis
2021 · Suiyuan Hu, Chu Lin, et al. · Mediators of Inflammation · 29
PDF
Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice
2024 · Fang Lv, Xiaoling Cai, et al. · Pharmaceuticals · 24
PDF
Chimeric antigen receptor engineered innate immune cells in cancer immunotherapy
2019 · Chu Lin, Jun Zhang · Science China Life Sciences · 24
The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis
2024 · Chu Lin, Suiyuan Hu, et al. · Pharmacological Research · 18
Glycemic control and the incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of randomized controlled trials
2020 · Chu Lin, Xiaoling Cai, et al. · Endocrine · 16
Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China
2020 · Xiaoling Cai, Fang Zhang, et al. · Diabetes Metabolic Syndrome and Obesity · 16
PDF
SGLT2i increased the plasma fasting glucagon level in patients with diabetes: A meta-analysis
2021 · Xingyun Zhu, Chu Lin, et al. · European Journal of Pharmacology · 15
Assessment of ovarian reserve in patients with type 1 diabetes: a systematic review and meta-analysis
2022 · Wenjia Yang, Chu Lin, et al. · Endocrine · 14
One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA
2024 · Mengqing Zhang, Chu Lin, et al. · Diabetes Obesity and Metabolism · 13
Baseline eGFR, albuminuria and renal outcomes in patients with SGLT2 inhibitor treatment: an updated meta-analysis
2023 · Yunke Ma, Chu Lin, et al. · Acta Diabetologica · 13
Evaluation of efficacy and safety of glucokinase activators—a systematic review and meta-analysis
2023 · Wenjia Yang, Han Wu, et al. · Frontiers in Endocrinology · 12
PDF
Weight reduction and the risk of gallbladder and biliary disease: A systematic review and meta‐analysis of randomized clinical trials
2024 · Wenjia Yang, Han Wu, et al. · Obesity Reviews · 11
Dipeptidyl peptidase 4-inhibitor treatment was associated with a reduced incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of 115 randomized controlled trials with 121961 participants
2022 · Zonglin Li, Chu Lin, et al. · Expert Opinion on Investigational Drugs · 11
The Effects of Supervised Exercise Training on Weight Control and Other Metabolic Outcomes in Patients With Type 2 Diabetes: A Meta-Analysis
2022 · Xingyun Zhu, Fang Zhang, et al. · International Journal of Sport Nutrition and Exercise Metabolism · 11
Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
2021 · Xiaoling Cai, Chu Lin, et al. · Diabetes & Metabolism Journal · 11
PDF
Works count: 79
Citation count: 907
H-index: 16
I10-index: 28
Year
Topic
Type